The presently disclosed subject matter relates to a method for selecting a compound of haploid induction. The method includes: treating a reproductive tissue of a plant with a reagent containing compounds to be tested; detecting a reactive oxygen species (ROS) level in the reproductive tissue after the treatment; and determining a compound that leads to an increase of the ROS level as the compound.

The presently disclosed subject matter relates to a method for selecting a compound of haploid induction. The method includes: treating a reproductive tissue of a plant with a reagent containing compounds to be tested; detecting a reactive oxygen species (ROS) level in the reproductive tissue after the treatment; and determining a compound that leads to an increase of the ROS level as the compound.

It was found that plants with loss of functional Msi2 protein due to a nucleotide polymorphism resulting in the introduction of a premature stop codon in the Msi2 protein, are able to induce haploid offspring after a cross to or with a wild type plant comprising a functional Msi2 protein. The invention relates to generation of haploid and doubled haploid plants.

It was found that plants with loss of functional Msi2 protein due to a nucleotide polymorphism resulting in the introduction of a premature stop codon in the Msi2 protein, are able to induce haploid offspring after a cross to or with a wild type plant comprising a functional Msi2 protein. The invention relates to generation of haploid and doubled haploid plants.

Embodiments of the present disclosure are directed to a method that includes treating a Cannabis plant, plant part, or plant cell with a solution including a chemical agent configured to modify a ploidy level of the Cannabis plant, plant part, or plant cell. The method further includes, in response to the treatment, modifying the ploidy level of the cannabis plant, plant part, or plant cell.

Embodiments of the present disclosure are directed to a method that includes treating a Cannabis plant, plant part, or plant cell with a solution including a chemical agent configured to modify a ploidy level of the Cannabis plant, plant part, or plant cell. The method further includes, in response to the treatment, modifying the ploidy level of the cannabis plant, plant part, or plant cell.

The present invention relates to non-transgenic and transgenic plants, preferably crop plants, comprising at least one mutation of the KINTEOCHORE NULL2 (KNL2) protein, especially a mutation causing a substitution of an amino acid within the KNL2 protein, preferably within the C-terminal region of the KNL2 protein, which preferably have the biological activity of a haploid inducer. Further, the present invention provides methods of generating the plants of the present invention and haploid and double haploid plants obtainable by crossing the plants of the present invention with wildtype plants as well as methods of facilitating cytoplasm exchange.

The present invention relates to non-transgenic and transgenic plants, preferably crop plants, comprising at least one mutation of the KINTEOCHORE NULL2 (KNL2) protein, especially a mutation causing a substitution of an amino acid within the KNL2 protein, preferably within the C-terminal region of the KNL2 protein, which preferably have the biological activity of a haploid inducer. Further, the present invention provides methods of generating the plants of the present invention and haploid and double haploid plants obtainable by crossing the plants of the present invention with wildtype plants as well as methods of facilitating cytoplasm exchange.

The invention provides novel methods to genotype haploid embryos using molecular assays. For example, quantitative methods for genotyping are provided. The methods provided also include providing a plurality of haploid kernels, determining the genotype of the haploid embryo of said kernels by distinguishing its genotype from the endosperm genotype, selecting a kernel having a desired genotype and producing doubled haploid plant from the selected kernel.

The invention provides novel methods to genotype haploid embryos using molecular assays. For example, quantitative methods for genotyping are provided. The methods provided also include providing a plurality of haploid kernels, determining the genotype of the haploid embryo of said kernels by distinguishing its genotype from the endosperm genotype, selecting a kernel having a desired genotype and producing doubled haploid plant from the selected kernel.